ANIK
Anika Therapeutics Inc
Price:  
10.59 
USD
Volume:  
83,115.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Anika Intrinsic Value

-61.30 %
Upside

What is the intrinsic value of Anika?

As of 2025-06-21, the Intrinsic Value of Anika Therapeutics Inc (ANIK) is 4.10 USD. This Anika valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 10.59 USD, the upside of Anika Therapeutics Inc is -61.30%.

The range of the Intrinsic Value is 3.63 - 10.79 USD

Is Anika undervalued or overvalued?

Based on its market price of 10.59 USD and our intrinsic valuation, Anika Therapeutics Inc (ANIK) is overvalued by 61.30%.

10.59 USD
Stock Price
4.10 USD
Intrinsic Value
Intrinsic Value Details

Anika Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) 3.63 - 10.79 4.10 -61.3%
DCF (Growth 10y) 6.27 - 48.89 9.12 -13.9%
DCF (EBITDA 5y) 8.31 - 10.03 9.24 -12.7%
DCF (EBITDA 10y) 10.12 - 13.11 11.66 10.1%
Fair Value -19.79 - -19.79 -19.79 -286.83%
P/E (38.23) - (65.45) (53.82) -608.2%
EV/EBITDA 5.56 - 9.36 7.08 -33.1%
EPV 18.35 - 23.78 21.06 98.9%
DDM - Stable (43.94) - (277.39) (160.67) -1617.1%
DDM - Multi 3.38 - 17.51 5.77 -45.5%

Anika Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 151.86
Beta 0.92
Outstanding shares (mil) 14.34
Enterprise Value (mil) 98.49
Market risk premium 4.60%
Cost of Equity 7.53%
Cost of Debt 5.00%
WACC 5.60%